Literature DB >> 17595941

Cardiovascular disease and African Americans: why determination of race is inadequate for research and practice.

Keith C Ferdinand.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17595941      PMCID： PMC2574385     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN： 0027-9684            Impact factor:   1.798


× No keyword cloud information.
  14 in total

1.  Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks.

Authors:  Janice G Douglas; George L Bakris; Murray Epstein; Keith C Ferdinand; Carlos Ferrario; John M Flack; Kenneth A Jamerson; Wendell E Jones; Julian Haywood; Randall Maxey; Elizabeth O Ofili; Elijah Saunders; Ernesto L Schiffrin; Domenic A Sica; James R Sowers; Donald G Vidt
Journal:  Arch Intern Med       Date:  2003-03-10

2.  Aldosterone synthase promoter polymorphism predicts outcome in African Americans with heart failure: results from the A-HeFT Trial.

Authors:  Dennis M McNamara; S William Tam; Michael L Sabolinski; Page Tobelmann; Karen Janosko; Anne L Taylor; Jay N Cohn; Arthur M Feldman; Manuel Worcel
Journal:  J Am Coll Cardiol       Date:  2006-08-14       Impact factor: 24.094

3.  Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.

Authors:  Anne L Taylor; Susan Ziesche; Clyde Yancy; Peter Carson; Ralph D'Agostino; Keith Ferdinand; Malcolm Taylor; Kirkwood Adams; Michael Sabolinski; Manuel Worcel; Jay N Cohn
Journal:  N Engl J Med       Date:  2004-11-08       Impact factor: 91.245

4.  The association between birthplace and mortality from cardiovascular causes among black and white residents of New York City.

Authors:  J Fang; S Madhavan; M H Alderman
Journal:  N Engl J Med       Date:  1996-11-21       Impact factor: 91.245

5.  Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

Authors:  Jackson T Wright; George Bakris; Tom Greene; Larry Y Agodoa; Lawrence J Appel; Jeanne Charleston; DeAnna Cheek; Janice G Douglas-Baltimore; Jennifer Gassman; Richard Glassock; Lee Hebert; Kenneth Jamerson; Julia Lewis; Robert A Phillips; Robert D Toto; John P Middleton; Stephen G Rostand
Journal:  JAMA       Date:  2002-11-20       Impact factor: 56.272

6.  A novel variant of the beta-subunit of the amiloride-sensitive sodium channel in African Americans.

Authors:  Y R Su; M P Rutkowski; C A Klanke; X Wu; Y Cui; R Y Pun; V Carter; M Reif; A G Menon
Journal:  J Am Soc Nephrol       Date:  1996-12       Impact factor: 10.121

7.  Comparison of efficacy and safety of rosuvastatin versus atorvastatin in African-American patients in a six-week trial.

Authors:  Keith C Ferdinand; Luther T Clark; Karol E Watson; Ryan C Neal; Clinton D Brown; B Waine Kong; Boisey O Barnes; William R Cox; Franklin J Zieve; Jonathan Isaacsohn; Joseph Ycas; Philip T Sager; Alex Gold
Journal:  Am J Cardiol       Date:  2005-11-28       Impact factor: 2.778

8.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

9.  Eight Americas: investigating mortality disparities across races, counties, and race-counties in the United States.

Authors:  Christopher J L Murray; Sandeep C Kulkarni; Catherine Michaud; Niels Tomijima; Maria T Bulzacchelli; Terrell J Iandiorio; Majid Ezzati
Journal:  PLoS Med       Date:  2006-09       Impact factor: 11.069

10.  An international comparative study of blood pressure in populations of European vs. African descent.

Authors:  Richard S Cooper; Katharina Wolf-Maier; Amy Luke; Adebowale Adeyemo; José R Banegas; Terrence Forrester; Simona Giampaoli; Michel Joffres; Mika Kastarinen; Paola Primatesta; Birgitta Stegmayr; Michael Thamm
Journal:  BMC Med       Date:  2005-01-05       Impact factor: 8.775
View more
  3 in total

1.  Changes in Central Aortic Pressure, Endothelial Function and Biomarkers in Hypertensive African-Americans with the Cardiometabolic Syndrome: Comparison of Amlodipine/Olmesartan versus Hydrochlorothiazide/Losartan.

Authors:  Bobby V Khan; Nadya Merchant; Syed T Rahman; Mushtaq Ahmad; Janice M Parrott; Kanwal Umar; Julie Johnson; Keith C Ferdinand
Journal:  Cardiorenal Med       Date:  2013-10-02       Impact factor: 2.041

2.  Nebivolol in high-risk, obese African Americans with stage 1 hypertension: effects on blood pressure, vascular compliance, and endothelial function.

Authors:  Nadya Merchant; Charles D Searles; Anbu Pandian; Syed T Rahman; Keith C Ferdinand; Guillermo E Umpierrez; Bobby V Khan
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-12       Impact factor: 3.738

3.  Novel Neurovascular Protective Agents: Effects of INV-155, INV-157, INV-159, and INV-161 versus Lipoic Acid and Captopril in a Rat Stroke Model.

Authors:  Barry J Connell; Bobby V Khan; Desikan Rajagopal; Tarek M Saleh
Journal:  Cardiol Res Pract       Date:  2012-01-04       Impact factor: 1.866
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.